TPG Growth has announced that it would invest $30 million in Solara Active Pharma, a leading global manufacturer of active pharmaceutical ingredients (API) with a network of customers including several top global generic companies in the US and Europe and a robust selection of products.

The investment will be focused on supporting Solara Active Pharma's growth initiatives as they expand capacity in regulated markets. The transaction is expected to close in early 2019 subject to shareholder and regulatory approval.

The investment builds on TPG's position as one of the world's largest healthcare investors, with more than $13 billion in equity capital invested across the sector globally.

The investment also marks TPG Growth's first investment in India focused on life sciences, a growing sector where it is able to leverage its global healthcare portfolio and experience to gain unique insights into the market, as well as its extensive business building capability.